Discovery of Potent Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L
I. Meewan, J. Kattoula, J. Kattoula, D. Skinner, P. Fajtov, M. Giardini, B. Woodworth, J. McKerrow, J. Siqueira-Neto, A. J. O'Donoghue, R. Abagyan
This paper identifies potent triple inhibitors targeting SARS-CoV-2 proteases and human cathepsin L, showing improved potency and antiviral effects compared to disulfiram.
bioRxiv · Oct 19, 2021Pharmacology & Toxicology